PTC Therapeutics

Press Releases

The press releases contained in this archive section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. PTC Therapeutics disavows any obligation to update the information contained in such press releases after the date of their issuance.

 
Press Releases
  Date Title and Summary View
Mar 19, 2018
SOUTH PLAINFIELD, N.J., March 19, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on March 13, 2018 it approved non-statutory stock options to purchase an aggregate of 25,200 shares of its common stock to six new employees. The awards were made pursuant to the NASDAQ inducement grant exception as a component of the n...
Mar 15, 2018
SOUTH PLAINFIELD, N.J., March 15, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the FIREFISH study of RG7916 in Type 1 spinal muscular atrophy (SMA) patients has transitioned into its pivotal phase with the dosing the first patient. Spinal muscular atrophy is a rare neuromuscular disorder that is caused by reduced ...
Mar 6, 2018
SOUTH PLAINFIELD, N.J., March 6, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2017. "Our mission for the past 20 years has been to develop and bring treatments to patients with rare genetic disorders," said...
Mar 1, 2018
SOUTH PLAINFIELD, N.J., March 1, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that management will present a company update at the following conferences: Cowen and Company 38th Annual Health Care Conference, on Wednesday, March 14th at 8:00 a.m. ET Barclays Global Healthcare Conference 2018, on Thursday, ...
Feb 28, 2018
SOUTH PLAINFIELD, N.J., Feb. 28, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on February 26, 2018 it approved non-statutory stock options to purchase an aggregate of 96,750 shares of its common stock to sixteen new employees.  The awards were made pursuant to the NASDAQ inducement grant exception as a component o...
Feb 21, 2018
SOUTH PLAINFIELD, N.J., Feb. 21, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its fourth quarter and year end 2017 financial results and provide an update on the company's business and outlook on Tuesday, March 6, 2018 at 4:30 p.m. (ET) after closing of the...
Feb 20, 2018
SOUTH PLAINFIELD, N.J., Feb. 20, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Office of New Drugs of the U.S. Food and Drug Administration has reiterated the FDA's prior position and denied PTC's appeal of the Complete Response Letter in relation to the New Drug Application (NDA) for ataluren. In its letter, t...
Feb 13, 2018
SOUTH PLAINFIELD, N.J., Feb. 13, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) is delighted to announce the launch of the fourth annual STRIVE (Strategies to Realize Innovation, Vision and Empowerment) grant award program for Duchenne Muscular Dystrophy (DMD). The STRIVE Awards provide funds to patient advocacy organizations to develop...
Feb 9, 2018
SOUTH PLAINFIELD, N.J., Feb. 9, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the company will present a company overview at the upcoming 2018 RBC Capital Markets Global Healthcare Conference on Thursday, February 22nd at 2:35 pm ET. The presentation will be webcast live on the Events and Presentations page...
Jan 27, 2018
SOUTH PLAINFIELD, N.J., Jan. 27, 2018 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced the presentation of early interim data from Part 1, the dose-finding portion of the FIREFISH study. FIREFISH is a two-part seamless, open-label, multi-center study to investigate the safety and efficacy of RG7916 in infants and babies with Ty...
Page: FirstPrevious
2
... NextLast
= add release to Briefcase
You are now leaving this website. If you would like to continue, click Continue.
CancelContinue